公开(公告)号：US10022416B2

公开(公告)日：2018-07-17

申请号：US14540212

申请日：2014-11-13

申请人： LAILA PHARMACEUTICALS PVT. LTD.

发明人： Ravichandran Sripathy ,  Venkata Narasimha Siva Rama Raju Mandapati ,  Gopaal Ajay ,  Nirvanashetty Somashekara ,  Ramchand Nanappan Chaniyilparampu ,  Rama Raju Gokaraju ,  Ganga Raju Gokaraju ,  Kiran Bhupathiraju ,  Dwarakanath Anjana

IPC分类号： A61K36/9066 ,  A61K9/51 ,  A61K9/00 ,  A61K9/10 ,  A61K9/107 ,  A61K36/9068 ,  A61K36/16 ,  A61K36/185 ,  A61K36/258 ,  A61K36/38 ,  A61K36/53 ,  A61K31/12 ,  A61K31/047 ,  A61K31/05 ,  A61K31/122 ,  A61K31/19 ,  A61K31/353 ,  A61K31/366 ,  A61K31/704 ,  A61K47/10 ,  A61K47/26

摘要： A highly bioavailable, water soluble, sustained release nanoformulation comprising a hydrophobic plant derived compound(s) in an emulsifier phase, and aqueous phase. The formulation provides sustained release of the hydrophobic plant derived compound(s) over a 24 hr time period. A process for preparation of the water soluble nanoformulation is described.